메뉴 건너뛰기




Volumn 5, Issue 6, 2013, Pages 549-551

Cytotoxic T lymphocytes: The future of cancer stem cell eradication?

Author keywords

cancer stem cell; cytotoxic T lymphocyte; immunotherapy; tumor antigen

Indexed keywords

SIPULEUCEL T; TRANSCRIPTION FACTOR NANOG; TUMOR ANTIGEN;

EID: 84878736628     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.13.44     Document Type: Review
Times cited : (10)

References (17)
  • 1
    • 79952370202 scopus 로고    scopus 로고
    • The cancer stem cell: Premises, promises and challenges
    • Clevers H. The cancer stem cell: premises, promises and challenges. Nat. Med. 17, 313-319 (2011).
    • (2011) Nat. Med. , vol.17 , pp. 313-319
    • Clevers, H.1
  • 2
    • 77953455668 scopus 로고    scopus 로고
    • Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells
    • Hirohashi Y, Torigoe T, Inoda S et al. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells. Immunotherapy 2, 201-211 (2010).
    • (2010) Immunotherapy , vol.2 , pp. 201-211
    • Hirohashi, Y.1    Torigoe, T.2    Inoda, S.3
  • 3
    • 79953668877 scopus 로고    scopus 로고
    • Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells
    • Inoda S, Hirohashi Y, Torigoe T et al. Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells. Am. J. Pathol. 178, 1805-1813 (2011).
    • (2011) Am. J. Pathol. , vol.178 , pp. 1805-1813
    • Inoda, S.1    Hirohashi, Y.2    Torigoe, T.3
  • 4
    • 84874260704 scopus 로고    scopus 로고
    • Human NK cells selective targeting of colon cancer-initiating cells: A role for natural cytotoxicity receptors and MHC class i molecules
    • Tallerico R, Todaro M, Di Franco S et al. Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. J. Immunol. 190, 2381-2390 (2013).
    • (2013) J. Immunol. , vol.190 , pp. 2381-2390
    • Tallerico, R.1    Todaro, M.2    Di Franco, S.3
  • 5
    • 69249149701 scopus 로고    scopus 로고
    • Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens
    • Xu Q, Liu G, Yuan X et al. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells 27, 1734-1740 (2009).
    • (2009) Stem Cells , vol.27 , pp. 1734-1740
    • Xu, Q.1    Liu, G.2    Yuan, X.3
  • 6
    • 80053542413 scopus 로고    scopus 로고
    • Targeting ALDH (bright) human carcinoma-initiating cells with ALDH1A1-specific CD8+ T cells
    • Visus C, Wang Y, Lozano-Leon A et al. Targeting ALDH (bright) human carcinoma-initiating cells with ALDH1A1-specific CD8+ T cells. Clin. Cancer Res. 17, 6174-6184 (2011).
    • (2011) Clin. Cancer Res. , vol.17 , pp. 6174-6184
    • Visus, C.1    Wang, Y.2    Lozano-Leon, A.3
  • 8
    • 34247212827 scopus 로고    scopus 로고
    • Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
    • Schmitz M, Temme A, Senner V et al. Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. Br. J. Cancer 96, 1293-1301 (2007).
    • (2007) Br. J. Cancer , vol.96 , pp. 1293-1301
    • Schmitz, M.1    Temme, A.2    Senner, V.3
  • 9
    • 33750431017 scopus 로고    scopus 로고
    • The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
    • Steele JC, Torr EE, Noakes KL et al. The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens. Br. J. Cancer 95, 1202-1211 (2006).
    • (2006) Br. J. Cancer , vol.95 , pp. 1202-1211
    • Steele, J.C.1    Torr, E.E.2    Noakes, K.L.3
  • 10
  • 11
    • 84861906424 scopus 로고    scopus 로고
    • HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells
    • Nishizawa S, Hirohashi Y, Torigoe T et al. HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res. 72, 2844-2854 (2012).
    • (2012) Cancer Res , vol.72 , pp. 2844-2854
    • Nishizawa, S.1    Hirohashi, Y.2    Torigoe, T.3
  • 12
    • 84877636710 scopus 로고    scopus 로고
    • Preferential expression of cancer/testis (CT) genes in cancer stem-like cells: Proposal of a novel sub-category, cancer/testis/stem (CTS) gene
    • doi:10.1111/tan.12113 Epub ahead of print
    • Yamada R, Takahashi A, Torigoe T et al. Preferential expression of cancer/testis (CT) genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem (CTS) gene. Tissue Antigens doi:10.1111/tan.12113. (2013) (Epub ahead of print).
    • (2013) Tissue Antigens
    • Yamada, R.1    Takahashi, A.2    Torigoe, T.3
  • 13
    • 2942591945 scopus 로고    scopus 로고
    • The cancer/testis genes: Review, standardization, and commentary
    • Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun. 4, 1 (2004).
    • (2004) Cancer Immun , vol.4 , pp. 1
    • Scanlan, M.J.1    Simpson, A.J.2    Old, L.J.3
  • 15
    • 84859394263 scopus 로고    scopus 로고
    • Cancer stem cell vaccination confers significant antitumor immunity
    • Ning N, Pan Q, Zheng F et al. Cancer stem cell vaccination confers significant antitumor immunity. Cancer Res. 72, 1853-1864 (2012).
    • (2012) Cancer Res , vol.72 , pp. 1853-1864
    • Ning, N.1    Pan, Q.2    Zheng, F.3
  • 16
    • 74549187948 scopus 로고    scopus 로고
    • Glioma-associated cancer-initiating cells induce immunosuppression
    • Wei J, Barr J, Kong LY et al. Glioma-associated cancer-initiating cells induce immunosuppression. Clin. Cancer Res. 16, 461-473 (2010).
    • (2010) Clin. Cancer Res. , vol.16 , pp. 461-473
    • Wei, J.1    Barr, J.2    Kong, L.Y.3
  • 17
    • 84868618042 scopus 로고    scopus 로고
    • Nanog signaling in cancer promotes stem-like phenotype and immune evasion
    • Noh KH, Kim BW, Song KH et al. Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J. Clin. Invest. 22(11), 4077-4093 (2012).
    • (2012) J. Clin. Invest. , vol.22 , Issue.11 , pp. 4077-4093
    • Noh, K.H.1    Kim, B.W.2    Song, K.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.